Stanley Lipkowitz

25PUBLICATIONS
125CO-AUTHORS
Molecular targetsNeural engineeringCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 26, 2026
Preclinical modeling of trastuzumab deruxtecan in a mouse model of brain metastatic triple-negative breast cancer identifies two contributors to efficacy.

|Oct 08, 2026
TR-107, a novel mitochondrial ClpP agonist, induces robust antitumor activity against preclinical models of adrenocortical carcinoma.

|Sep 24, 2026
DVT-primed neutrophils reshape the brain microenvironment to promote brain metastasis.

|Jun 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclax.

|Jun 04, 2026
Loss of Flotillin-2 enhances trastuzumab emtansine internalization and cytotoxicity by relieving negative regulation of HER2 internalization in HER2-amplified cancers.

|Mar 17, 2026
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study.

Junya Tabata, Tzu-Ting Huang, Elena Giudice

Pageof 5

Frequent Collaborators

6 joint publications

Yoshimi Greer

4 joint publications

Alexandra Zimmer

3 joint publications

Nahoko Sato

3 joint publications

Takeo Fujii